Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry
Realistic expectations focus on appetite control and metabolic health support, not the dramatic results seen in randomized controlled trials of prescription GLP 1 medications
GHK-Cu stimulates collagen I, III, and elastin synthesis in fibroblasts Promotes decorin and glycosaminoglycan production for matrix integrity Attracts immune cells and promotes wound debridement and repair GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes2012Gene Expression Gene expression analysis reveals GHK-Cu upregulates antioxidant genes and downregulates pro-inflammatory genes, suggesting a protective role against oxidative stress and UV damage in skin
However, in patients whose stomachs already struggle to move food efficiently, adding a medication that further slows this process could theoretically worsen symptoms
Neuroprotective and Neurotrophic Actions of Glucagon-Like Peptide-1: An Emerging Opportunity to Treat Neurodegenerative and Cerebrovascular Disorders
For example, over two years, total costs averaged ~$51,794 for surgical patients vs ~$63,483 for GLP-1 therapy